Are prostaglandins mediators of mifepristone (RU 486)-induced cervical softening in early pregnancy?
Rådestad
A
A
Department of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden.
Bygdeman
M
M
D016718:Arachidonic Acid / Q000378:metabolism; D001696:Biomechanical Phenomena; D002584:Cervix Uteri / Q000187:drug effects* / Q000502:physiology; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D015735:Mifepristone / Q000494:pharmacology*; D009288:Naproxen / Q000494:pharmacology; D011247:Pregnancy; D011453:Prostaglandins / Q000096:biosynthesis / Q000502:physiology*
D011453:Prostaglandins; D016718:Arachidonic Acid; D015735:Mifepristone; D009288:Naproxen